vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and NaaS Technology Inc. (NAAS). Click either name above to swap in a different company.

Amarin Corp plc is the larger business by last-quarter revenue ($45.1M vs $25.9M, roughly 1.7× NaaS Technology Inc.). Amarin Corp plc runs the higher net margin — -23.3% vs -193.3%, a 170.0% gap on every dollar of revenue. On growth, NaaS Technology Inc. posted the faster year-over-year revenue change (121.2% vs 7.0%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

NaaS Technology Inc. is a leading electric vehicle energy service provider based in China. It delivers one-stop solutions covering charging network operation, software and hardware support for charging station operators, and value-added services such as charging location search and payment for EV owners, serving both enterprise and individual customers across domestic and select overseas markets.

AMRN vs NAAS — Head-to-Head

Bigger by revenue
AMRN
AMRN
1.7× larger
AMRN
$45.1M
$25.9M
NAAS
Growing faster (revenue YoY)
NAAS
NAAS
+114.2% gap
NAAS
121.2%
7.0%
AMRN
Higher net margin
AMRN
AMRN
170.0% more per $
AMRN
-23.3%
-193.3%
NAAS

Income Statement — Q1 FY2026 vs Q2 FY2024

Metric
AMRN
AMRN
NAAS
NAAS
Revenue
$45.1M
$25.9M
Net Profit
$-10.5M
$-50.0M
Gross Margin
29.2%
Operating Margin
35.5%
-144.2%
Net Margin
-23.3%
-193.3%
Revenue YoY
7.0%
121.2%
Net Profit YoY
33.0%
18.4%
EPS (diluted)
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
NAAS
NAAS
Q1 26
$45.1M
Q4 25
$49.2M
Q3 25
$49.7M
Q2 25
$72.7M
Q1 25
$42.0M
Q4 24
$62.3M
Q3 24
$42.3M
Q2 24
$67.5M
$25.9M
Net Profit
AMRN
AMRN
NAAS
NAAS
Q1 26
$-10.5M
Q4 25
$-1.2M
Q3 25
$-7.7M
Q2 25
$-14.1M
Q1 25
$-15.7M
Q4 24
$-48.6M
Q3 24
$-25.1M
Q2 24
$1.5M
$-50.0M
Gross Margin
AMRN
AMRN
NAAS
NAAS
Q1 26
Q4 25
47.1%
Q3 25
44.7%
Q2 25
69.2%
Q1 25
59.8%
Q4 24
-15.4%
Q3 24
38.5%
Q2 24
63.4%
29.2%
Operating Margin
AMRN
AMRN
NAAS
NAAS
Q1 26
35.5%
Q4 25
-12.9%
Q3 25
-22.4%
Q2 25
-22.0%
Q1 25
-39.9%
Q4 24
-84.3%
Q3 24
-59.5%
Q2 24
-0.8%
-144.2%
Net Margin
AMRN
AMRN
NAAS
NAAS
Q1 26
-23.3%
Q4 25
-2.5%
Q3 25
-15.6%
Q2 25
-19.4%
Q1 25
-37.4%
Q4 24
-78.0%
Q3 24
-59.4%
Q2 24
2.3%
-193.3%
EPS (diluted)
AMRN
AMRN
NAAS
NAAS
Q1 26
Q4 25
$0.00
Q3 25
$-0.02
Q2 25
$-0.03
Q1 25
$-0.04
Q4 24
$-0.12
Q3 24
$-0.06
Q2 24
$0.00
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
NAAS
NAAS
Cash + ST InvestmentsLiquidity on hand
$307.8M
$24.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$-33.4M
Total Assets
$645.8M
$180.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
NAAS
NAAS
Q1 26
$307.8M
Q4 25
$302.6M
Q3 25
$286.6M
Q2 25
$298.7M
Q1 25
$281.8M
Q4 24
$294.2M
Q3 24
$305.7M
Q2 24
$306.7M
$24.7M
Stockholders' Equity
AMRN
AMRN
NAAS
NAAS
Q1 26
Q4 25
$459.3M
Q3 25
$458.9M
Q2 25
$464.9M
Q1 25
$473.7M
Q4 24
$486.2M
Q3 24
$531.4M
Q2 24
$551.9M
$-33.4M
Total Assets
AMRN
AMRN
NAAS
NAAS
Q1 26
$645.8M
Q4 25
$670.8M
Q3 25
$659.8M
Q2 25
$670.1M
Q1 25
$655.7M
Q4 24
$685.3M
Q3 24
$750.6M
Q2 24
$799.9M
$180.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
NAAS
NAAS
Operating Cash FlowLast quarter
$-25.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
NAAS
NAAS
Q1 26
Q4 25
$15.3M
Q3 25
$-12.7M
Q2 25
$16.6M
Q1 25
$-12.5M
Q4 24
$-13.3M
Q3 24
$-2.4M
Q2 24
$-2.7M
$-25.7M
Cash Conversion
AMRN
AMRN
NAAS
NAAS
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

NAAS
NAAS

Segment breakdown not available.

Related Comparisons